Add to ORKGMethylphenidate is used for the treatment of attention deficit hyperactivity disorder in children above the age of 6 with a high safety and tolerability. When used above the recommended dosage, methylphenidate has been reported to cause toxicity symptoms including neuro-psychiatric and cardiac adverse reactions. In this overview paper, the available literature on psyhcostimulant toxicity in children and the clinical symptoms and follow-up of a 4-year-old child who accidentally used high dose of methylphenidate will be discussed. [Archives Medical Review Journal 2013; 22(2.000): 184-193
Attention Deficit and Hyperactivity Disorder (ADHD) is among the most commonly encountered neurodeve...
Three classes (height/weight, cardiovascular, and somatic complaints) of treatment emergent symptoms...
The effects of methylphenidate in thirty children, ages 6 to 16, with epilepsy and ADHD were evaluat...
The use of psychostimulants labeled to treat attention deficit/hyperactivity disorder increases. Amo...
Previous studies have suggested that risk of psychotic events may be increased in children exposed t...
ABSTRACT The purpose of this article is to examine the association of adverse cardiovascular risks w...
As atypical antipsychotics are increasingly used in the treatment of childhood behavioural disorders...
Attention Deficit and Hyperactivity Disorder (ADHD) is among the most commonly encountered neurodeve...
Therapeutic dose of methylphenidate is known to cause adverse effects (psychosis or mania), albeit i...
BACKGROUND: Children and adolescents with attention deficit hyperactivity disorder (ADHD) are at hig...
Methylphenidate, which blocks the presynaptic norepinephrine and dopamine transporters, is the most ...
Introduction. Hyperkinetic disorder or attention-deficit hyperactivity disorder (ADHD) is a clinica...
A growing number of studies show an association between attention deficit hyperactivity disorder and...
Methylphenidate (MPH), the most common medication for children with Attention Deficit/Hyperactivity ...
Objective: The aim of the current study was to determine various aspects of methylphenidate adverse ...
Attention Deficit and Hyperactivity Disorder (ADHD) is among the most commonly encountered neurodeve...
Three classes (height/weight, cardiovascular, and somatic complaints) of treatment emergent symptoms...
The effects of methylphenidate in thirty children, ages 6 to 16, with epilepsy and ADHD were evaluat...
The use of psychostimulants labeled to treat attention deficit/hyperactivity disorder increases. Amo...
Previous studies have suggested that risk of psychotic events may be increased in children exposed t...
ABSTRACT The purpose of this article is to examine the association of adverse cardiovascular risks w...
As atypical antipsychotics are increasingly used in the treatment of childhood behavioural disorders...
Attention Deficit and Hyperactivity Disorder (ADHD) is among the most commonly encountered neurodeve...
Therapeutic dose of methylphenidate is known to cause adverse effects (psychosis or mania), albeit i...
BACKGROUND: Children and adolescents with attention deficit hyperactivity disorder (ADHD) are at hig...
Methylphenidate, which blocks the presynaptic norepinephrine and dopamine transporters, is the most ...
Introduction. Hyperkinetic disorder or attention-deficit hyperactivity disorder (ADHD) is a clinica...
A growing number of studies show an association between attention deficit hyperactivity disorder and...
Methylphenidate (MPH), the most common medication for children with Attention Deficit/Hyperactivity ...
Objective: The aim of the current study was to determine various aspects of methylphenidate adverse ...
Attention Deficit and Hyperactivity Disorder (ADHD) is among the most commonly encountered neurodeve...
Three classes (height/weight, cardiovascular, and somatic complaints) of treatment emergent symptoms...
The effects of methylphenidate in thirty children, ages 6 to 16, with epilepsy and ADHD were evaluat...